DB17680ExperimentalProtein Based Therapies
PRX-OTC is an intracellular enzyme replacement therapy designed to replace missing or defective enzyme in patients with ornithine transcarbamylase deficiency.
- Also known as
- PRX OTC
Which companies are running trials of PRX-OTC, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account